BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 29853611)

  • 1. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.
    Chillon A; Zuccato D
    PDA J Pharm Sci Technol; 2019; 73(3):235-246. PubMed ID: 30651335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of autoclavation on baked-on siliconized containers for biologics.
    Moll F; Bechtold-Peters K; Friess W
    Eur J Pharm Biopharm; 2023 Jun; 187():184-195. PubMed ID: 37142129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals.
    Felsovalyi F; Janvier S; Jouffray S; Soukiassian H; Mangiagalli P
    J Pharm Sci; 2012 Dec; 101(12):4569-83. PubMed ID: 23023774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
    Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers.
    Basu P; Krishnan S; Thirumangalathu R; Randolph TW; Carpenter JF
    J Pharm Sci; 2013 Mar; 102(3):852-65. PubMed ID: 23280943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel silicone oil free primary packaging system with PTFE-based barrier stopper for biologics.
    Moll F; Bechtold-Peters K; Friess W
    Eur J Pharm Biopharm; 2023 Sep; 190():206-219. PubMed ID: 37536577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silicone Oil-Free Polymer Syringes for the Storage of Therapeutic Proteins.
    Werner BP; Schöneich C; Winter G
    J Pharm Sci; 2019 Mar; 108(3):1148-1160. PubMed ID: 30391415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of syringes and vials for delivery of biologics: current challenges and innovative solutions.
    Yoneda S; Torisu T; Uchiyama S
    Expert Opin Drug Deliv; 2021 Apr; 18(4):459-470. PubMed ID: 33217252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
    Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
    J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vapor-Phase Hydrogen Peroxide Uptake by Silicone Tubing and Primary Packaging Components during Protein Drug Product Aseptic Filling: Impact of Pretreatment and Sterilization Process.
    Eisner DR; Hubbard A; Eppler K; Tegoulia V; Maa YF
    PDA J Pharm Sci Technol; 2019; 73(5):443-458. PubMed ID: 31004039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
    Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
    Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the initial level and migration of silicone oil lubricant in empty prefilled syringes for biologics using infrared spectroscopy.
    Bee JS; Frey VV; Javed U; Chung J; Corcoran ML; Roussel PS; Krause SO; Cash PW; Bishop SM; Dimitrova MN
    PDA J Pharm Sci Technol; 2014; 68(5):494-503. PubMed ID: 25336420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic.
    Waxman L; Vilivalam VD
    PDA J Pharm Sci Technol; 2017; 71(6):462-477. PubMed ID: 28819049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
    Teska BM; Brake JM; Tronto GS; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silicone Migration From Baked-on Silicone Layers. Particle Characterization in Placebo and Protein Solutions.
    Funke S; Matilainen J; Nalenz H; Bechtold-Peters K; Mahler HC; Friess W
    J Pharm Sci; 2016 Dec; 105(12):3520-3531. PubMed ID: 27773525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System.
    Shi GH; Gopalrathnam G; Shinkle SL; Dong X; Hofer JD; Jensen EC; Rajagopalan N
    PDA J Pharm Sci Technol; 2018; 72(1):50-61. PubMed ID: 29030531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing the Emulsion for Bake-on Siliconization of Containers-Comparison of Emulsion Stability and Container Performance in the Context of Protein Formulations.
    Moll F; Bechtold-Peters K; Mellman J; Sigg J; Friess W
    PDA J Pharm Sci Technol; 2022; 76(2):89-108. PubMed ID: 35365551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.